A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

2,220

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Interventions
OTHER

Background care

Guidelines-based medical care

DRUG

Placebo

Matching dalcetrapib placebo orally daily

DRUG

dalcetrapib

600 mg orally daily

Trial Locations (241)

1036

Budapest

1133

Budapest

2650

Hvidovre

2750

Ballerup Municipality

2900

Komárom

3220

Geelong

4025

Debrecen

4064

Milton

4600

Kisvárda

6027

Joondalup

7100

Vejle

7621

Pécs

8142

Úrhida

8200

Århus N

8800

Nagykanizsa

10461

The Bronx

10567

Cortlandt Manor

11650

Mexico City

11787

Smithtown

12180

Troy

12211

Albany

12601

Poughkeepsi

12866

Saratoga Springs

13202

Syracuse

14215

Buffalo

14380

D. F.

16502

Erie

16550

Erie

16602

Altoona

16684

Tipton

17011

Camp Hill

18105

Allentowm

18901

Doylestown

19047

Langhorne

19114

Philadelphia

19153

Philadelphia

19380

West Chester

19446

Lansdale

19464

Pottstown

20109

Manassas

20230

Aguascalientes

Aguascaliente

20705

Beltsville

21804

Salisbury

22601

Winchester

22908

Charlottesville

23249

Richmond

24501

Lynchburg

27710

Durham

27804

Rocky Mount

27909

Elizabeth City

28009

Madrid

28401

Wilmington

28557

Morehead City

28602

Hickory

28625

Statesville

28803

Asheville

29010

Málaga

29471

Benátky nad Jizerou

29621

Anderson

29651

Greer

30014

Covington

30033

Decatur

30041

Cumming

31217

Chihuahua City

32114

Daytona Beach

32117

Daytona Beach

32216

Jacksonville

32308

Tallahassee

32401

Panama City

33317

Plantation

33401

West Palm Beach

33472

Boynton Beach

33604

Pessac

33613

Tampa

33907

Fort Myers

33952

Port Charlotte

34080

Durango

35801

Huntsville

37604

Johnson City

38000

Celaya

40205

Louisville

42086

Pachuca

43076

Thornville

43623

Toledo

43701

Zanesville

44060

Mentor

44195

Cleveland

44600

Guadalajara

44650

Guadalajara

44670

Guadalajara

44827

Mansfield

45227

Cincinnati

46237

Indianapolis

46250

Indianapolis

46601

South Bend

46617

Elkhart

47303

Muncie

48197

Ypsilanti

48307

Rochester Hills

48602

Saginaw

48670

Midland

49048

Kalamazoo

49201

Jackson

49855

Marquette

56303

Saint Cloud

57701

Rapid City

58103

Fargo

59901

Kalispell

60190

Winfield

60504

Aurora

61201

Rock Island

62250

Cuernavaca

63017

Chesterfield

64020

Monterrey

64060

Monterrey

64111

Kansas City

65201

Columbia

66215

Overland Park

71301

Alexandria

75251

Dallas

75701

Tyler

76000

Querétaro

77338

Humble

78200

San Luis Potosí City

San Luís Potosí

78240

San Luis Potosi S.l.p.

79761

Odessa

80124

Lonetree

80218

Denver

80909

Colorado Springs

84004

Provo

89000

Tampico

90503

Torrance

90509

Torrance

92103

San Diego

92704

Santa Ana

92801

Anaheim

92835

Fullerton

95405

Santa Rosa

100050

Beijing

280146

Madrid

330006

Nanchang

35294-0007

Birmingham

06606

Bridgeport

06102

Hartford

46320-1942

Hammond

04401

Bangor

02111

Boston

01830

Haverhill

02601

Hyannis

02747

North Dartmouth

55905-0001

Rochester

03060

Nashua

08103

Camden

08035

Haddon Heights

07803

Mine Hill

07470

Wayne

07675

Westwood

12206-1098

Albany

19454-2053

North Wales

24541-4160

Danville

V3K 3P4

Coquitlam

V1Y 1T2

Kelowna

V5Z 1M9

Vancouver

E1C 4B7

Moncton

L1S 7K8

Ajax

L4M 7G1

Barrie

L7M 4Y1

Burlington

N1R 7R1

Cambridge

P3E 2N8

Greater Sudbury

P3E 3B8

Greater Sudbury

N6A 5G6

London

L6K 3W7

Oakville

L1H 1B9

Oshawa

L1J 2K1

Oshawa

P7B 6V4

Thunder Bay

M4G 3E8

Toronto

J2G 8Z9

Granby

J4V 3G8

Greenfield Park

H8S 2E4

Lachine

J4M 2X1

Longueuil

J4N 1C2

Longueuil

J7J 2K8

Mirabel

H1T 1C8

Montreal

H1T 3Y7

Montreal

H2K 4L5

Montreal

H3J 2V5

Montreal

G1J 1Z4

Québec

G1V 4M6

Québec

J4P 2H4

Saint-Lambert

G8T 7A1

Trois-Rivières

J9P 3Y1

Val-d'Or

050035

Shijiazhuang

377 01

Jindřichův Hradec

722 00

Ostrava

530 02

Pardubice

140 00

Prague

274 01

Slaný

541 01

Trutnov

1815 JD

Alkmaar

1105 AZ

Amsterdam

7334 DZ

Apeldoorn

4818 CK

Breda

2625 AD

Delft

5611 NJ

Eindhoven

5632 EJ

Eindhoven

2803 HH

Gouda

9711 SG

Groningen

6419 PC

Heerlen

1624 NP

Hoorn

2300 RC

Leiden

3021 HC

Rotterdam

3045 PM

Rotterdam

3584 CX

Utrecht

6883 ES

Velp

5912 BL

Venlo

2724 EK

Zoetermeer

15-879

Bialystok

80-286

Gdansk

81-384

Gdynia

40-748

Katowice

30-069

Krakow

90-302

Lodz

91-425

Lodz

20-015

Lublin

20-044

Lublin

20-538

Lublin

61-655

Poznan

24-100

Pulway

41-709

Ruda Śląska

01-192

Warsaw

02-097

Warsaw

04009

Almería

08003

Barcelona

B15 2SQ

Birmingham

CF14 5GJ

Cardiff

G20 0SP

Glasgow

L22 0LG

Liverpool

M15 6SX

Manchester

RG2 0TG

Reading

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01516541 - A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease | Biotech Hunter | Biotech Hunter